Updates on the regulatory framework for the life science industry were highlighted during the second open forum hosted by Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments’ Sciences Cluster, in conjunction with the Ministry of Health (MoH).
Led by His Excellency Dr.Amin Al Amiri,Asst. Under-Secretary for Medical Practice and license (CEO) and Chairman of Supreme National Blood Transfusion Committee UAE, the event brought together business leaders and regulators to network, share knowledge and discuss best practices in the life science industry. Perspectives on a new law for the import and export of pharmaceutical products were also shared by senior officials from the Ministry of Health.
H.E. Dr Amin Al Amiri said: “Open forums such as these offer valuable opportunities to share updates on the regulatory environment in the UAE. We are confident the new law on the import and export of pharmaceutical products will prevent the trade of spurious goods in the market.
“The biotechnology sector is witnessing rapid growth and the Ministry of Health believes strategic partnerships such as that with DuBiotech will help address challenges and offer enhanced support to private sector companies in the life sciences park. This comes as part of our larger objective to safe-guard the well-being of the people of the UAE and the region.”
Dr Ayesha Abdullah, Managing Director of the Sciences’ Cluster at TECOM Investments, said: “We constantly seek avenues to collaborate with the Ministry of Health and government entities to ensure that we address the concerns and queriesall of our business partners and update them on new regulatory legislations for the biotechnology sector. We look forward to hosting more of such initiatives as part of our endeavour to create an enabling environment at the DuBiotechpark.”